Danish Biotech Stock News

In August 2026, DFDS A/S reported that July freight volumes were 3,451,000 lane metres and passenger numbers 752,000, alongside second-quarter sales of DKK 8,584 million and a return to quarterly profitability versus a loss a year earlier. The company also raised its 2026 revenue growth outlook to 3–5% and lifted the low end of its EBIT range to DKK 1,200 million–1,400 million, while announcing a planned change of Board Chair at an extraordinary general meeting in September. We’ll now...

Carlsberg (CPSE:CARL B) has given investors fresh numbers to assess after reporting half year 2026 results, with sales of DKK 47,053 million and net income of DKK 3,801 million. See our latest analysis for Carlsberg. Carlsberg’s share price is DKK 881.6 after a 2.04% 1 day share price gain, although the 30 day share price return is down 6.01%. Over the past year, total shareholder return is 17.06%, while the 3 year and 5 year total shareholder returns show small declines. This suggests...

Shipping routes are being rewritten in real time as the Panama Canal cuts daily ship transits and trade frictions shift between major economies. That disruption can reshuffle pricing power and cargo volumes, which means some globally exposed stocks may gain fresh momentum while others struggle to adjust. This article walks through three stocks from a Global Shipping and Logistics Beneficiaries screener and explains how each is positioned in this new trade reality. The three stocks covered...

Quarterly earnings trigger fresh focus on UIE stock UIE (CPSE:UIE) is back on investor watch after its 19 August earnings release, which showed higher second quarter sales and net income, alongside sharply lower profit and earnings per share for the first half of 2026. See our latest analysis for UIE. The recent earnings update has arrived alongside a 12.15% 90 day share price return to DKK397.0 and a 38.58% 1 year total shareholder return. This suggests stronger momentum building around...

A week ago, H. Lundbeck A/S ( CPH:HLUN B ) came out with a strong set of second-quarter numbers that could potentially...

GN Store Nord (CPSE:GN) shares reacted to a busy set of updates after the company upgraded its 2026 adjusted EBITA margin guidance and confirmed progress on the planned sale of its hearing business. See our latest analysis for GN Store Nord. At a share price of DKK94.14, GN Store Nord has seen a 1 day share price return of 4.37%, while the 1 year total shareholder return is down 21.22%. This suggests that recent momentum contrasts with weaker long term performance as investors reassess the...

ISS (CPSE:ISS) drew investor attention after reporting half year 2026 results, reaffirming its full year earnings guidance and expanding its share buyback authorization. The update combined operational data with a clearer view of capital returns. See our latest analysis for ISS. The latest earnings update and larger buyback sit against a share price of DKK292.0, with a 90 day share price return of 10.19% and a year to date share price return of 35.44%. Over longer horizons, total shareholder...

North Media entered this earnings day as a value puzzle. The stock trades on a P/E of 4.5x against a European media peer group closer to the mid teens, yet the share price slipped around the Q2 release, with a 7 day return of roughly 3% down. The headline is simple: Q2 2026 delivered a sharp swing back into profit with basic earnings per share of DKK7.6 on net income of DKK137.1 million. The market is weighing that against questions on earnings quality and a discounted cash flow value that...

Why Demant’s latest earnings and product launch matter for investors Demant (CPSE:DEMANT) has just paired half year 2026 earnings, with higher sales and net income, and launched Oticon Reveal, a new AI powered rechargeable hearing aid, putting both financial and product performance in focus. See our latest analysis for Demant. At a share price of DKK286.0, Demant has seen a 15.70% 90 day share price return and a 34.02% year to date share price return, while the 5 year total shareholder return...

TCM Group stock closed at DKK67.6 on Friday, capping a run of weak short term returns with the shares down about 3% over both one month and three months. Yet behind that soft tape sits a kitchen maker that just printed Q2 revenue of DKK374.8m and kept full year guidance intact. The real story is not the quarter’s modest earnings per share of DKK1.61. It is a business leaning on free cash flow and margin repair to support a low 9.3x trailing P/E and a balance sheet carrying high debt. The next...

Gubra stock has been on a tear in recent months, closing at DKK390.2 and sitting on a double digit gain over 30 and 90 days. Yet the fresh H1 2026 report tells a tougher story on the income statement, with revenue of DKK126.3m sitting beside a net loss of DKK110.0m. The real headline is not this half year loss. It is the tension between heavy investment in obesity and peptide drug discovery on one side and a valuation that already prices in a lot of future success on the other. Short term...

SP Group stock has barely moved over the past month, yet the latest earnings land with far more force than the share price suggests. You are looking at a company trading on a P/E of 16.8x while delivering record first half 2026 results and a trailing net margin of 9.7%. The real story sits beyond today’s tick-by-tick moves. Revenue is running close to DKK 3.4b on a trailing twelve month basis, and earnings over the past year are reported up 32.4%. For long term holders, the question is how...

cBrain arrived at this earnings print with a strong recent share run and a valuation that already reflected high growth expectations. The stock closed at DKK74 after the report, leaving investors to weigh a familiar software trade off. Revenue for H1 2026 came in at DKK140.0m with net income of DKK27.9m, while the trailing 12 month net margin sits at 18.1%, below the prior year level. The central question is whether that margin pressure reflects a temporary investment choice or a more...

Dampskibsselskabet Norden (CPSE:DNORD) drew fresh attention after reporting second quarter 2026 sales of US$1,047.4 million and net income of US$100.8 million, alongside a higher floor for its full year net profit guidance. See our latest analysis for Dampskibsselskabet Norden. The strong second quarter update and raised guidance appear to sit behind a clear upswing in Dampskibsselskabet Norden's share price, with a 6.45% 1 month share price return and a 39.66% year to date share price...

A week ago, FLSmidth & Co. A/S ( CPH:FLS ) came out with a strong set of quarterly numbers that could potentially lead...

The quarterly results for Coloplast A/S ( CPH:COLO B ) were released last week, making it a good time to revisit its...

ALK-Abelló stock went into the earnings release under pressure, down roughly 20% over the past three months, yet the latest numbers tell a more resilient story. The company just posted trailing twelve month revenue of DKK 6,561m and earnings from continuing operations of DKK 1,280m, with a net profit margin near 19.5%. The key question for you now is whether that profit profile justifies a P/E of about 36x in a sector where many peers trade at far lower multiples. The rest of the earnings...

GN Store Nord stock came into this earnings print under pressure, down about 12% over the past week and weaker over the past quarter as well. The headline from Q2 is not a growth story. The group booked a loss from continuing operations and reported basic earnings per share of DKK 1.56 in the red, even though revenue from continuing operations reached DKK 2,171m. The key issue for investors is the balance sheet and valuation strain. Net interest bearing debt of DKK 9.6b remains heavy, while...

Columbus stock closed at DKK9.8 heading into the first full trading day after its earnings release, with recent returns only slightly in the red over one, three and six months. The headline from the numbers is not growth. It is the squeeze on profitability. Trailing net profit margin is 0.4% compared with 2.9% a year earlier, and earnings in the most recent year turned negative, even as revenue stayed in the billion-krona range. For an IT services company, that gap between volume and profit...

The market came into GrønlandsBANKEN’s Q2 numbers with the stock drifting, down about 7% over the past month and slightly weaker over the past week. Yet the headline from these results is not the share price; it is the squeeze on profitability in a bank already wrestling with elevated bad loans. Revenue for Q2 landed at DKK 117.429 million while net income came in at DKK 45.864 million, well below the strong Q1 run rate. For a bank often viewed through a value lens, with a P/E of 10.4x and a...

The market has barely flinched on Lån & Spar Bank, with the stock almost flat over the last month despite a clear earnings jolt in Q2. Basic earnings per share jumped to DKK36.80 as net income reached DKK127.21m, putting profit strength at the center of this release. For a bank already trading on a P/E of 11.3x and priced well below some valuation estimates, that level of profitability sets up a sentiment clash. Short term price action looks cautious, while the Q2 numbers highlight an...

Lollands Bank comes into this earnings season with a stock that has been quietly grinding higher, up about 2.1% over the past week and 2.5% over three months, while trading on a modest P/E of 10.4x. The headline from Q2 is simple: profitability is the story. Net profit margins over the last year sit at 30.8% compared with 29.5% a year earlier, and earnings have risen 3.3% over that period. For a regional bank, that margin profile is the key tension between the muted share price moves and what...

Novozymes stock went into today on a strong run, with the share price up about 17% over the past three months and trading on a rich P/E near 45x. That kind of optimism sets a high bar. The earnings headline is clear. Organic sales in the first half grew 8% with adjusted earnings before interest, tax, depreciation and amortization margin at 37.7%, and management lifted full year organic growth guidance to 7 to 8% with margin expected at the top of the 37 to 38% range. Is Novozymes at 45x P/E a...

Carlsberg stock has drifted lower in recent weeks, with the share price down about 7% over the past month even as H1 results landed with solid headline growth. The earnings story that matters most is not the revenue print. It is the squeeze on profitability that shows up in a trailing net margin of 7.1% compared with 8.1% a year earlier. Short term traders are reacting to the chart. Long term holders are more likely focused on a company that still carries a premium P/E multiple and high debt,...